jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Mumps Virus IgM antibody

Bacterial/ Viral
image

Report in 48Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Detects acute mumps infection.

592846

30% OFF

Mumps Virus IgM Antibody Test - Complete Medical Guide

  • Why is it done?
    • Test Description: Detects IgM antibodies against mumps virus in the bloodstream, indicating acute or recent infection
    • Primary Indications: Suspected acute mumps infection with clinical symptoms such as parotitis (swollen salivary glands), fever, and malaise
    • Clinical Presentations: Bilateral parotid gland enlargement, meningitis, encephalitis, orchitis, oophoritis, or pancreatitis with compatible symptoms
    • Timing: Typically performed during acute phase of illness or within first 4-5 days of symptom onset for optimal detection; may be ordered during disease outbreak investigations
    • Outbreak Settings: Differential diagnosis in epidemiologic investigations and confirmation of suspected mumps cases in vaccinated populations
  • Normal Range
    • Reference Values: Negative or <0.9 index value (results vary by laboratory assay method and platform used)
    • Common Index Ranges: Negative: <0.9 index
    • Borderline: 0.9-1.1 index (may require repeat testing or additional confirmation)
    • Positive: >1.1 index value, indicating acute mumps infection
    • Units: Index value (dimensionless), some labs report as positive/negative or may use titer levels (typically 1:64 or higher considered positive)
    • Clinical Interpretation: Negative result means no acute mumps infection detected; positive indicates acute or recent infection; borderline requires clinical correlation and possible repeat testing
  • Interpretation
    • Positive IgM Result: Strongly suggestive of acute mumps infection; IgM appears first during infection (within 3-4 days of symptom onset) and typically persists for 2-3 months
    • Negative IgM Result: May indicate no acute infection, testing performed too early (<72 hours from symptom onset), or past immunity; does not rule out mumps if strong clinical suspicion exists
    • Borderline/Equivocal: May represent early infection or false positive; repeat testing in 7-10 days recommended or paired acute/convalescent sera comparison
    • Clinical Significance of Timing: IgM positivity indicates infection occurred in past 1-3 months; after this window, IgG antibodies dominate; early testing may miss early infections requiring repeat testing
    • Factors Affecting Results: Immunocompromised status may result in delayed or absent antibody response; recent MMR vaccination may cause false positives; heterophile antibodies and rheumatoid factor may interfere; sample collection timing critical for accuracy
    • Serial Testing Interpretation: A four-fold rise in titer between acute and convalescent sera collected 2-4 weeks apart confirms recent infection; paired samples provide gold standard for diagnosis
  • Associated Organs
    • Primary Organ Systems: Salivary glands (particularly parotid glands), central nervous system, reproductive organs, and pancreas
    • Commonly Associated Conditions: Acute parotitis (parotid gland inflammation), viral meningitis, encephalitis, and aseptic meningitis
    • Reproductive Manifestations: Orchitis (testicular inflammation) in males, oophoritis (ovarian inflammation) in females, with potential impact on fertility
    • Pancreatic Involvement: Mumps pancreatitis causing abdominal pain, elevated amylase and lipase levels; usually self-limited
    • Neurological Complications: Mumps meningitis most common complication; mumps encephalitis with altered mental status; post-infectious encephalomyelitis
    • Hearing Loss Risk: Sensorineural hearing loss potentially permanent; unilateral or bilateral; risk increased in severe infections
    • Other Associated Complications: Myocarditis, mastitis, thyroiditis, and temporary diabetes; congenital mumps in infected pregnant women during first trimester
  • Follow-up Tests
    • Mumps IgG Antibody: Ordered for immunity verification and to determine if prior infection or vaccination occurred; positive IgG with negative IgM indicates past infection or immunity
    • Mumps Virus Culture or RT-PCR: Definitive diagnosis via viral culture from saliva, cerebrospinal fluid, or urine; RT-PCR more sensitive and rapid; useful if serology inconclusive
    • Cerebrospinal Fluid Analysis: Indicated if meningitis or encephalitis suspected; includes cell count, protein, glucose, viral PCR, and mumps serology on CSF
    • Serum Amylase and Lipase: Measured if pancreatitis suspected; elevated levels support diagnosis of mumps-associated pancreatitis
    • Audiometry Testing: Recommended after acute mumps to assess for sensorineural hearing loss; baseline for comparison if permanent damage suspected
    • Repeat Mumps IgM Serology: Recommended 7-10 days after initial negative test if strong clinical suspicion remains; paired acute/convalescent sera for four-fold titer rise confirmation
    • Complete Blood Count: May show relative lymphocytosis; supports viral infection diagnosis but not specific for mumps
    • Liver Function Tests: To assess for mumps-related hepatitis; ordered if elevated transaminases or jaundice present
  • Fasting Required?
    • Fasting Requirement: No - Fasting is NOT required for Mumps Virus IgM antibody serology testing
    • Sample Collection: Simple venipuncture for serum collection; can be performed at any time of day regardless of meal intake; no special patient preparation needed
    • Timing Considerations: Collect sample within first 4-5 days of symptom onset for optimal IgM detection; drawing early in disease course maximizes sensitivity
    • Medications: No medications need to be avoided; continue all regular medications as prescribed; test results not affected by pharmaceutical agents
    • Special Instructions: Inform healthcare provider if recently vaccinated with MMR vaccine (may cause false positive); disclose any current immunocompromised status; avoid strenuous exercise immediately before collection if possible
    • Additional Specimen Collection Notes: Ensure proper tube (serum separator tube), label correctly with patient identifiers, date and time of collection; maintain proper temperature during transport; deliver to laboratory promptly for processing

How our test process works!

customers
customers